RVU (RVU) News
Follow RVU (RVU) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Ryvu Therapeutics Q2 net loss 13.1 million zlotys
Ryvu Therapeutics reported a Q2 net loss of 13.1 million zlotys.
EQUITY | Sep 17, 2026, 05:01 AM UTC
L
Ryvu Therapeutics “Dualis” project recommended for 22.2 mln zloty subsidy
Ryvu Therapeutics’ “Dualis” project was recommended for a 22.2 million zloty subsidy.
EQUITY | Sep 07, 2026, 04:01 PM UTC